|
WO2020145222A1
|
|
Novel neoantigens and cancer immunotherapy using same
|
|
WO2019117132A1
|
|
Biomarker for prognostic prediction of cancer immunotherapy
|
|
WO2017150497A1
|
|
Diagnosis support system for lesion in lung field, and method and program for controlling same
|
|
EP3418304A1
|
|
Recognition of membrane type mucin-like protein and clinical application thereof
|
|
US2017049870A1
|
|
Antigen Peptide Derived From the Sequence of Epidermal Growth Factor Receptor Having T790M Point Mutation
|
|
JP2017060551A
|
|
Isocenter evaluation device
|
|
WO2015115545A1
|
|
Method for evaluating of metastasis or risk of recurrence of breast cancer
|
|
EP2883884A1
|
|
Antigen peptide originated from t790m point-mutated sequence of epidermal growth factor receptor
|
|
AU2011272235A1
|
|
Prediction device, prediction method, program, and recording medium
|
|
JP2011180130A
|
|
Method for measuring amine in biological sample, and screening method of patient using the same method
|
